MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: A study on inter-observer agreement

Brain

Volumn 128, Issue 9, 2005, Pages 2026-2033

  Tschampa, Henriette J ^a   Kallenberg, Kai ^b   Urbach, Horst ^a   Meissner, Bettina ^b   Nicolay, Claudia ^a   Kretzschmar, Hans A ^c   Knauth, Michael ^b   Zerr, Inga ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Creutzfeldt Jakob disease; Dementia; Diagnostic criteria; Diffusion; MRI

Indexed keywords

ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; ELECTROENCEPHALOGRAM; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; ELECTROENCEPHALOGRAPHY; EVALUATION; METHODOLOGY; OBSERVER VARIATION; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKER; PROTEIN 14 3 3; YWHAB PROTEIN, HUMAN;

14-3-3 PROTEINS; BIOLOGICAL MARKERS; CREUTZFELDT-JAKOB SYNDROME; ELECTROENCEPHALOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 24344453861     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh575     Document Type: Article

References (26)

1. Bahn MM, Kido DK, Lin W, Pearlman AL. Brain magnetic resonance diffusion abnormalities in Creutzfeldt-Jakob disease. Arch Neurol 1997; 54: 1411-5.
2. Bahn MM, Parchi P. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol 1999; 56: 577-83.
3. Collie DA, Sellar RJ, Zeidler M, Colchester AC, Knight R, Will RG. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 2001; 56: 726-39.
4. Collie DA, Summers DM, Sellar RJ, Ironside JW, Copper S, Zeidler M, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Am J Neuroradiol 2003; 24: 1560-9.
5. Finkenstaedt M, Szudra A, Zerr I, Poser S, Hise JH, Stoebner JM, et al. MR imaging of Creutzfeldt-Jakob disease. Radiology 1996; 199: 793-8.
6. Fleiss J. Measuring nominal scale agreement among many raters. Psych Bull 1971; 76: 378-82.
7. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 913-20.
8. Kropp S, Finkenstaedt M, Zerr I, Schroter A, Poser S. Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease. Nervenarzt 2000; 71: 91-5.
9. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5: 177-88.
10. Newcombe R, Altman D. Proportions and their differences. In: Altman D, Machin D, Bryant T, Gardner M, editors. Statistics with confidence. British Medical Journal Books, Bristol, 2000: 45-56.
11. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windi O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-33.
12. Poser S, Mollenhauer B, Kraubeta A, Zerr I, Steinhoff BJ, Schroeter A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999; 122 (Pt 12): 2345-51.
13. Schroter A, Zerr I, Henkel K, Tschampa HJ, Finkenstaedt M, Poser S. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 2000; 57: 1751-7.
14. Sellars RJ, Collie DA, Will RJ. Progress in understanding Creutzfeldt-Jakob disease. Am J Neuroradiol 2002; 23: 1070-2.
15. Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 63: 443-9.
16. Steinhoff BJ, Racker S, Herrendorf G, Poser S, Grosche S, Zerr I, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 162-6.
17. Tschampa HJ, Murtz P, Flacke S, Paus S, Schild HH, Urbach H. Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study. Am J Neuroradiol 2003; 24: 908-15.
18. Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi L. MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 1998; 40: 65-70.
19. Urbach H, Paus S, Tschampa HJ, Keller E, Schild HH. Creutzfeldt-Jakob disease: value of MRI. Rofo Fortschr. Geb. Rontgenstr. Neuen Bildgeb. Verfahr 2001; 173: 509-14.
20. Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000; 47: 575-82.
21. World Health Organization. Human transmissible spongiform encephalopathies. Weekly Epidemiological Record 1998; 73: 361-5.
22. Zeidler M, Will RG, Ironside JW, Sellar R, Wardlaw J. Magnetic resonance imaging is not a sensitive test for Creutzfeldt-Jakob disease. BMJ 1996; 312: 844.
23. Zeidler M, Sellar RJ, Collie DA, Knight R, Stewart G, Macleod MA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000; 355: 1412-8.
24. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43: 32-40.
25. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro CJ, Knight RS, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000a; 55: 811-15.
26. Zerr I, Schulz-Schaeffer WJ, Giese A, Bodemer M, Schroter A, Henkel K, et al. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 2000b; 48: 323-9.